Is Advanced Biomed Inc. Common Stock (ADVB) a Buy, Sell, or Hold?
NASDAQ : ADVB
Advanced Biomed Inc. Common Stock
$12.47 USD
$5.39 (76.13%)
- Volume
- 15.21M
- Average Volume
- 156.26K
- Market Capitalization
- $13.49M
- P/E Ratio
- -58.54
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $14.00
- Year Low
- $3.61
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.38
Company Overview
NASDAQ
Xiaomin Chen
Medical - Diagnostics & Research
Healthcare
ADVB
31
US
USD
Liquidity Metrics
0.08
7.38
7.38
1.83
0.00
Sales & Valuation
-$
0.00
1.74
-19.43
-0.54
Profitability
-$0.0938
-$101.52K
0.00%
0.00%
-20.71%
-6.36%
P/E Metrics
-58.54
0.08
0.08
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
1.23
1/9
$9.1M
$10.65M
$1.44M
-$1.06M
Key Metrics (TTM)
$7.51M
0.00
-7.48
7.38
-20.71%
-11.04%
-6.07%
-7.39%
-1513 days
Company Executives
| Name | Title |
|---|---|
| Xiaomin Chen | Chief Executive Officer & Chairman |
| Alan | Director of Investor Relations |
| Yi Lu | Chief Executive Officer & Chairman |
| Mingze Yin | CFO & Director |
| Hung To Pau | Secretary |
Poll Results
No votes yet today — be the first to share your view!
About Advanced Biomed Inc. Common Stock (NASDAQ:ADVB) Stock
Advanced Biomed Inc. functions as an investment holding company, primarily dedicated to the research and development of microfluidic biochip technologies. Based in Taiwan, the company leverages these innovations to enhance precision oncology, spanning cancer detection, diagnosis, and treatment. Its diverse product portfolio includes a suite of advanced devices: A+Pre: A fully automated system designed for pre-concentrating diluted blood samples. AC-1000: A rare cell device engineered to address the challenges of detecting cells in hypercoagulable samples from tumor patients. A+SCDrop: A specialized tool for capturing individual circulating tumor cells (CTCs). A+CellScan: An analyzer featuring an immunostaining chip, utilized for the immunostaining and analysis of output from the AC-1000. B ... eyond standalone devices, Advanced Biomed provides microfluidic biochips, including the A+Pre, AC-1000 CTC Enrichment, and A+CellScan chips, which are integral to delivering assay products and services to cancer patients. The company also offers a comprehensive range of immunochromogenic kits: A+CTCE kit: Used to identify epithelial circulating tumor cells by detecting EpCAM, CK (pan), CD45, and CD14 antibodies. A+CTCM kit: Targets mesenchymal circulating tumor cells through their expression of Vimentin, CD45, and CD14 antibodies. A+EMT kit: Designed for the identification of epithelial-to-mesenchymal circulating tumor cells, focusing on cell-surface Vimentin, CD45, and CD14 antibodies. A+CM kit: Facilitates the detection of tumor-associated macrophages by assessing PD-L1, CD45, and CD14 antibodies. In addition to its current offerings, Advanced Biomed is actively developing A+LCGuard, a promising solution for the early screening of lung cancer. The company further expands its presence by establishing and operating medical clinics in the People's Republic of China. Founded in 2014, Advanced Biomed Inc. maintains its corporate headquarters in New York, New York.
Frequently Asked Questions
-
What is the current Advanced Biomed Inc. Common Stock (ADVB) stock price?
-
Advanced Biomed Inc. Common Stock(NASDAQ:ADVB) stock price is $12.47 in the last trading session. During the trading session, ADVB stock reached the peak price of $14 while $3.61 was the lowest point it dropped to. The percentage change in ADVB stock occurred in the recent session was 76.13% while the dollar amount for the price change in ADVB stock was $5.39.
-
ADVB's industry and sector of operation?
-
The NASDAQ listed ADVB is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
-
Who are the executives of ADVB?
-
Xiaomin Chen | Chief Executive Officer & Chairman
Alan | Director of Investor Relations
Yi Lu | Chief Executive Officer & Chairman
Mingze Yin | CFO & Director
Hung To Pau | Secretary -
How many employees does ADVB have?
-
Number of ADVB employees currently stands at 31. ADVB operates from 122 East 42nd Street, New York City, NY 10168, US.
-
Link for ADVB official website?
-
Official Website of ADVB is: https://www.advanbiomed.com
-
How do I contact ADVB?
-
ADVB could be contacted at phone #+886 6 3121716 and can also be accessed through its website. ADVB operates from 122 East 42nd Street, New York City, NY 10168, US.
-
How many shares of ADVB are traded daily?
-
The average number of ADVB shares traded daily for last 3 months was 156.26K.
-
What is the market cap of ADVB currently?
-
The market value of ADVB currently stands at $13.49M with its latest stock price at $12.47